Do fair and just systems require compensation for the disadvantages of the natural lottery? a discussion on society's duties on the provision of gene therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Glybera EPAR summary for public https://www.ema.europa.eu/en/medicines/human/EPAR/glybera)https://www.ema.europa.eu/en/medicines/human/EPAR/glybera)Search in Google Scholar
Strimvelis EPAR summary for public https://www.ema.europa.eu/en/medicines/human/EPAR/strimvelis)https://www.ema.europa.eu/en/medicines/human/EPAR/strimvelis)Search in Google Scholar
Aiuti A, Roncarolo MG, Naldini L. Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: Paving the road for the next generation of advanced therapy medicinal products. EMBO Mol Med. 2017; 9(6): 737-740.10.15252/emmm.20170757328396566AiutiARoncaroloMGNaldiniLGene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: Paving the road for the next generation of advanced therapy medicinal products201796737740545204728396566Open DOISearch in Google Scholar
Food and Drug Administration. Approval History, Letters, Reviews, and Related Documents. IMLYGIC. 2015 https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm 469411.htm).Food and Drug Administration. Approval History, Letters, Reviews, and Related Documents2015https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm469411.htmSearch in Google Scholar
Food and Drug Administration. Approval History, Letters, Reviews and Related Documents. KYM-RIAH. 2017 https://www.fda.gov/Biologics Blood Vaccines/ CellularGeneTherapyProducts/Approved-Products/ ucm573706.htm).Food and Drug Administration. Approval History, Letters, Reviews and Related Documents2017https://www.fda.gov/Biologics Blood Vaccines/ CellularGeneTherapyProducts/Approved-Products/ucm573706.htm)Search in Google Scholar
Food and Drug Administration. Approval History, Letters, Reviews and Related Documents. YESCARTA. 2017 https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ ucm58122 2. htm).Food and Drug Administration. Approval History, Letters, Reviews and Related Documents2017https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm58122 2. htm)Search in Google Scholar
Food and Drug Administration. December 19, 2017 Approval Letter. LUXTURNA. 2017 https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm589507.htm)Food and Drug Administration. December 19, 2017 Approval Letter2017https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm589507.htm)Search in Google Scholar
Flotte TR. Ethical implications of the cost of molecularly targeted therapies. Hum Gene Ther. 2015; 26(9): 573-574.2635541410.1089/hum.2015.29010.trfFlotteTREthical implications of the cost of molecularly targeted therapies201526957357426355414Search in Google Scholar
Regalado A. The world's most expensive medicine is a bust. MIT Technol Rev. 2016 https://www.technologyreview.com/s/601165/the-worlds-most-expensive-medicine-is-a-bust/RegaladoAThe world's most expensive medicine is a bust2016https://www.technologyreview.com/s/601165/the-worlds-most-expensive-medicine-is-a-bust/Search in Google Scholar
Rawls JA. Theory of Justice (original ed). Cambridge, MA, USA: The Belknap Press, 2005; 60-65; 118-142.RawlsJACambridge, MA, USAThe Belknap Press200560-6511814210.2307/j.ctvjf9z6vSearch in Google Scholar
O'Brian WE Jr. Equality in law and philosophy. Inquiry. 2010; 53(3): 257-284. doi: 10.1080/00201741003784648.10.1080/00201741003784648O'BrianWE JrEquality in law and philosophy201053325728410.1080/00201741003784648Open DOISearch in Google Scholar
Buchanan A, Brock DW, Daniels N, Wilker D. From Chance to Choice. Genetics and Justice. Cambridge, Cambridgeshire, UK: University Press, 2000.BuchananABrockDWDanielsNWilkerDCambridge, Cambridgeshire, UKUniversity Press200010.1017/CBO9780511806940Search in Google Scholar
Daniels N. Just Health: Meeting Health Needs Fairly. New York, NY, USA: Cambridge University Press, 2008.DanielsNNew York, NY, USACambridge University Press200810.1017/CBO9780511809514Search in Google Scholar
Arneson RJ. Luck egalitarianism interpreted and defended. Philosophical Topics. 2004; 32(1-2): 1-20.10.5840/philtopics2004321/217ArnesonRJLuck egalitarianism interpreted and defended2004321-2120Open DOISearch in Google Scholar
Ekmekci PE, Arda, Β. Luck egalitarianism, individual responsibility and health. Balkan Med J. 2015; 32(3): 244-254.2618571110.5152/balkanmedj.2015.150012EkmekciPEArdaΒLuck egalitarianism, individual responsibility and health2015323244254449768926185711Search in Google Scholar